SCHEMBL5451154

SCHEMBL5451154

Cc1ccc(C=CC(=O)c2ccccc2Br)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.72
TP53 P04637 2/20 0.72
LMNA P02545 2/20 0.72
MAPT P10636 7/20 0.69
CYP3A4 P08684 2/20 0.61
HPGD P15428 2/20 0.61
MAOB P27338 5/20 0.58
MAOA P21397 4/20 0.58
ABCG2 Q9UNQ0 1/20 0.58
CYP1B1 Q16678 1/20 0.57
NFE2L2 Q16236 1/20 0.55
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
ALOX15 P16050 1/20 0.51
ALOX12 P18054 1/20 0.51
MAPK1 P28482 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5451151 1.00 ALDH1A1 (0.72) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL29429080 0.86 ALDH1A1 (0.76) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL14692643 0.86 ALDH1A1 (0.76) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL14692644 0.86 ALDH1A1 (0.76) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL25216133 0.85 TP53 (0.74) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL30384879 0.85 TP53 (0.74) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL25265248 0.85 TP53 (0.74) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL1320961 0.84 ALDH1A1 (0.72) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL28571268 0.84 ALDH1A1 (1.00) ALDH1A1TP53LMNAMAPTCYP3A4
SCHEMBL1320962 0.84 ALDH1A1 (0.72) ALDH1A1TP53LMNAMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070037807-A1 Pyridine compounds as inhibitors of dipeptidyl peptidase IV TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 US disclosed
EP-1678138-A1 PYRIDINE COMPOUNDS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV Takeda Pharmaceutical Company Limited (JP) 2006-07-12 EP disclosed
WO-2005042488-A1 PYRIDINE COMPOUNDS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070037807-A1 Pyridine compounds as inhibitors of dipeptidyl peptidase IV DPP4, DPP3, PEPD ALDH1A1 743/4885TP53 3215/4885LMNA 2641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.